AbbVie stock forecast and price prediction
Updated on:
May 17th, 2021
2
AbbVie forecast brief
- AbbVie just moved a -0.15% after hitting all-time highs last Friday
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.
AbbVie stock price forecast
Nobody can predict how much a stock will be priced in the future. Banks and financial organisations issue their analysis forecasting how a stock will performance in the future.
Along with buy or sell recommendations, brokerage institutions post their price target based on the stock price action and the company fundamental data. Most of these forecasts follow the publication of new fundamental information by the company, and many times. Again, these forecasts are not direct recommendations for individual investors and should not be followed blindly.
The average price target for AbbVie stock calculated from the table below is $127.50. That is a 9.51% than the current price ($116.43).
| Brokerage firm | Price target |
|---|---|
| Apr 30th, 2021 | |
| Piper Sandler | $120.00 → $124.00 |
| May 3rd, 2021 | |
| BMO Capital Markets | $127.00 → $129.00 |
| Mizuho | $126.00 → $128.00 |
| May 10th, 2021 | |
| BMO Capital Markets | $127.00 → $129.00 |
Analysts recommendations
In the last month, 4 ratings were published for AbbVie. General sentiment is bullish, with 4 out of 4 posting positive outlooks
| Brokerage firm | Rating |
|---|---|
| Apr 30th, 2021 | |
| Piper Sandler | Buy |
| May 3rd, 2021 | |
| BMO Capital Markets | Buy |
| Mizuho | |
| May 10th, 2021 | |
| BMO Capital Markets | Buy |
Earnings and financials
In late April, AbbVie Inc. ($ABBV) reported EPS for that slightly enhanced Wall St. expectations. Quarterly EPS was $2.95 per share compared to the forecasted $2.83. This quarterly report represents an earnings surprise of 4.24%. On the contrary, reported sales were $13.0 billion, in line with analysts' forecasts.
Compared to the same quarter one year ago, EPS was $2.42, so posted EPS is a gain of 21.90%. Revenue exploded a 50.95% on an annualized basis in the , from $86.2B to $130.1B last quarter.AbbVie ($ABBV) is hosting the Q2 earnings call next July. Market estimates of $3.08, compared to previous quarter that made $2.95.
AbbVie stock: buy or sell?
Is $ABBV stock a buy?
AbbVie received 4 ratings in the last 30 days: 4 bullish, 0 bearish and 0 neutral.In the current situation of AbbVie there is not any eligible buy setup. This doesn't mean we expect a selloff for $ABBV in coming sessions, or that it may not climb higher. Simply, it doesn't match our recommended trading systems
Should I sell AbbVie?
In the current situation of AbbVie there is not any eligible sell setup, so AbbVie stock holders with operations in profit can keep their positions
AbbVie stock price action predictions
$ABBV at new Highs
Last Friday, AbbVie hit all-time highs (ATH) again at $117.59. It's the sixth time in the last 10 sessions, marking an important rally
SMAs overview
Supports and resistances
Price is at all-time highs and there are not upper resistances.
The current supports are:
Bollinger bands
The price is moving near to the upper Bollinger band, signaling some level of overbought in recent sessions. This is not a sell signal, as price can trade in these levels for many days and weeks
Relative strength index
The RSI dropped below the overbought level of 70 last Tuesday after just crossing to the overbough zone for just one day (weak signal). The RSI reading last Friday was 68.33. Since RSI lost the overbought zone, AbbVie stock only moved a 0.18%
AbbVie stock price history
AbbVie went public on Jan 2nd, 2013 at $24.66 per share1. Since then, ABBV stock surged by 372.14%, with an average of 46.52% per year. An investment of $1,000USD on the IPO would have a value of $4,721.41 nowadays.
1: Adjusted price after possible price splits or reverse-splits
Important:
The viewpoints contained in this article are personal and should not be followed as recommendations for you to buy or sell stocks. The author of this report does not know the individual positions of the reader, his or her finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are posted for learning motives onlyAbbVie summary
| Friday, May 14th, 2021 | |
|---|---|
| Open | $117.36 |
| Close | $116.43 |
| Day range | $116.38 - $117.59 |
| Previous close | $116.6 |
| Session gain | -0.15% |
| Average true range | $2.26 |
| 50d mov avg | $108.36 |
| 100d mov avg | $106.69 |
| 200d mov avg | $98.75 |
| Earnings date | July 30th, 2021 |
Frequently asked questions
What is AbbVie stock symbol?
Will ABBV go up?
Latest AbbVie news
- Seeking AlphaAbbVie Should Benefit From A Buffett BounceNov 19, 2020